>>Lipids>> Sphingolipids>>1-β-D-Glucosylsphingadienine (d18:2 (4E,8E))

1-β-D-Glucosylsphingadienine (d18:2 (4E,8E)) (Synonyms: Glucosylsphingadienine (d18:2 (4E,8E)), 1-β-D-Glucosylsphingadienine (plant), Glucosylsphingosine (plant))

Catalog No.GC42050

1-β-D-글루코실스핑가디에닌(d18:2(4E,8E))은 글루코실세레브로사이드의 탈아세틸화된 리소지질 유도체인 글루코실스핑고신입니다.

Products are for research use only. Not for human use. We do not sell to patients.

1-β-D-Glucosylsphingadienine (d18:2 (4E,8E)) Chemical Structure

Cas No.: 114200-59-8

Size 가격 재고 수량
500μg
US$153.00
재고 있음
1mg
US$274.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

1-β-D-Glucosylsphingadienine is a glucosylsphingosine, which are deacetylated lysolipid derivatives of glucosylcerebrosides . They are formed when sphingosines undergo glucosidation by UDP-glucose. Glucosylsphingosines completely reduce neurite outgrowth and induce death of LA-N-2 cells at concentrations of 10 and 50 μM, respectively. They also decrease the activity of glucocerebrosidase in LA-N-2 cells in a dose-dependent manner. Glucosylsphingosine levels are elevated in patients with Gaucher's disease, both in the spleen (in types 1, 2, and 3) and brain (type 2 and 3); thus, glucosylsphingosine has been used as a key biomarker of the disease. This product contains 1-β-D-glucosylsphingadienine isolated from plants.

리뷰

Review for 1-β-D-Glucosylsphingadienine (d18:2 (4E,8E))

Average Rating: 5 ★★★★★ (Based on Reviews and 18 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 1-β-D-Glucosylsphingadienine (d18:2 (4E,8E))

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.